An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome von RUOTTINEN, H. M, PARTINEN, M, HUBLIN, C, BERGMAN, J, HAAPARANTA, M, SOLIN, O, RINNE, J. O

Volltext

Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [18F]CFT von Nurmi, E., Ruottinen, H. M., Kaasinen, V., Bergman, J., Haaparanta, M., Solin, O., Rinne, J. O.

Volltext

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations von Ruottinen, H M, Rinne, U K

Volltext

Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study von Nurmi, Elina, Ruottinen, Hanna M., Bergman, Jörgen, Haaparanta, Merja, Solin, Olof, Sonninen, Pirkko, Rinne, Juha O.

Volltext

[11C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: Correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology von LAMUSUO, S, PITKÄNEN, A, VAPALAHTI, M, VAINIO, P, RINNE, J. O, JUTILA, L, YLINEN, A, PARTANEN, K, KÄLVIÄINEN, R, RUOTTINEN, H.-M, OIKONEN, V, NAGREN, K, LEHIKOINEN, P

Volltext

Upregulation of Putaminal Dopamine D2 Receptors in Early Parkinson's Disease: A Comparative PET Study with [11C]Raclopride and [11C]N-Methylspiperone von Kaasinen, Valtteri, Ruottinen, Hanna M, Nagren, Kjell, Lehikoinen, Pertti, Oikonen, Vesa, Rinne, Juha O

Volltext

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease von RUOTTINEN, H. M, RINNE, U. K

Volltext

[18F]FDG‐PET and Whole‐Scalp MEG Localization of Epileptogenic Cortex von Lamusuo, S., Forss, N., Ruottinen, H‐M., Bergman, J., Mäkelä, J. P., Mervaala, E., Solin, O., Rinne, J. K., Ruotsalainen, U., Ylinen, A., Vapalahti, M., Hari, R., Rinne, J. O.

Volltext

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an internatio... von Odin, P, Ray Chaudhuri, K, Slevin, J.T, Volkmann, J, Dietrichs, E, Martinez-Martin, P, Krauss, J.K, Henriksen, T, Katzenschlager, R, Antonini, A, Rascol, O, Poewe, W

Volltext

Usefulness of a dopamine transporter PET ligand [18F]β-CFT in assessing disability in Parkinson's disease von Rinne, Juha O, Ruottinen, Hanna, Bergman, Jörgen, Haaparanta, Merja, Sonninen, Pirkko, Solin, Olof

Volltext

Pet shows that striatal dopamine D1 and D2 receptors are differentially affected in AD von KEMPPAINEN, N, RUOTTINEN, H, NAGREN, K, RINNE, J. O

Volltext

COMT inhibition in the treatment of Parkinson's disease von Ruottinen, H M, Rinne, U K

Volltext

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinso... von RUOTTINEN, H. M, RINNE, U. K

Volltext

Striatal uptake of the dopamine reuptake ligand [11C]β-CFT is reduced in Alzheimer's disease assessed by positron emission tomography von RINNE, J. O, SAHLBERG, N, RUOTTINEN, H, NAGREN, K, LEHIKOINEN, P

Volltext

Comparison of[18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex von Lamusuo, S, Ruottinen, H M, Knuuti, J, Härkönen, R, Ruotsalainen, U, Bergman, J, Haaparanta, M, Solin, O, Mervaala, E, Nousiainen, U, Jääskeläinen, S, Ylinen, A, Kälviäinen, R, Rinne, J K, Vapalahti, M, Rinne, J O

Volltext

Positron Emission Tomography Shows Reduced Striatal Dopamine D1 but not D2 Receptors in Juvenile Neuronal Ceroid Lipofuscinosis von Rinne, J. O., Ruottinen, H. M., Någren, K., Åberg, L. E., Santavuori, P.

Volltext

[18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease von O. Rinne, Juha, Nurmi, Elina, Ruottinen, Hanna M., Bergman, Jörgen, Eskola, Olli, Solin, Olof

Volltext

[18F]fluorodopa PET shows striatal dopaminergic dysfunction in juvenile neuronal ceroid lipofuscinosis von Ruottinen, H M, Rinne, J O, Haaparanta, M, Solin, O, Bergman, J, Oikonen, V J, Järvelä, I, Santavuori, P

Volltext

Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone von Trocóniz, Iñaki F., Naukkarinen, Tarja H., Ruottinen, Hanna M., Rinne, Urpo K., Gordin, Ariel, Karlsson, Mats O.

Volltext

Striatal uptake of a novel PET ligand, [18F]β-CFT, is reduced in early Parkinson's disease von Rinne, J.O., Bergman, J., Ruottinen, H., Haaparanta, M., Eronen, E., Oikonen, V., Sonninen, P., Solin, O.

Volltext